Regulatory & Legal
NewsData.io23 Sept 2026, 5:07 am ISTDelayed
Pfizer India responds to counterfeit drug investigation
What happened
- The Karnataka FDA canceled 16 drug licenses and suspended eight others due to alleged counterfeit medicine sales.
- Authorities seized machinery and medicines worth Rs 5.05 crore from an alleged illegal repacking operation.
- Pfizer India stated it is cooperating with authorities and has removed affected batches from the market.
Key terms explained
Financial terms from this story, in everyday words.
- Counterfeit
- Fake or imitation goods made to look like the original product.
- FDA
- Food and Drug Administration, a government body that regulates food and medicine safety.
Original source
NewsData.io
Was this summary clear?
For information only — not investment advice.Summarized automatically; always check the original before acting.

